The role of SNARE [soluble NSF (N-ethylmaleimide-sensitive factor) accessory protein receptor] protein in cellular trafficking, membrane fusion and vesicle release in synaptic nerve terminals is described. The purpose of this review is to highlight the role of SNAREs in vital inflammatory conditions in maturing dendritic cells in order to retain the capacity to present new antigens together with altered cytokine secretory functions. This role of SNAREs can be used as novel targets for therapy in inflammatory diseases. The essential mechanism of SNAREs proteins for regulation of tumour formation through multiple signals and transportation pathways is also discussed. Finally, this review summarizes the current knowledge of SNARE proteins in regulating endocytosis in cancer cells and the possible therapeutic applications related to the pathogenesis of tumor formation.
Introduction
Fusion of plasma membrane is achieved by the cooperation of various proteins, such as SNARE proteins, Rab GTPases and their effectors, and SNARE chaperones. SNARE proteins bring two membrane lipid bilayers into close proximity, which induces the fusion of the two close positioned membranes [1] . These SNAREs proteins have a characteristic coiled-coil SNARE motif of approximately 70 amino acids comprising heptad repeats.
Different Types of SNARE Complex Configuration
The neuronal SNAREs (syntaxin-1, SNAP25, and VAMP2) assemble to form a ternary complex that bridges the vesicle and the plasma membrane at some point during exocytosis. To produce sufficient force for membrane fusion, the trans-SNARE assembly cannot be as tight as the cis-SNARE assembly. Indeed, the trans-SNARE complex can be reversibly disassembled. The trans-SNARE state maybe the initial configuration required for exocytosis [12] .
The two types of the ternary SNARE complex, cis-and trans-, are showed in fusion process. Disassembly of cis-SNARE by NSF generates a "unitary-SNARE" state, in which each SNARE is not bound to other SNAREs [for details refer subtitle 1.2.2]. Subsequent assembly of t-SNAREs (syntaxin and SNAP25) generates a "binary-SNARE" complex, and then a v-SNARE (VAMP2) assembles with the binary complex to form a ternary transcSNARE complex linking the vesicle with the lipid bilayer [12] . If the trans-SNARE complex represents the initial state that triggers exocytosis, it needs to be protected from further SNARE assembly and fusion. In neuronal cell, synaptotagmin1 and complexin molecules have a clamping role for fusion of SNARE complex [13] . The two universally required components of the fusion machinery which play complementary functions in fusion are SNARE and SM (Sec1/Munc18-like) proteins. Vesicular (v-SNARE) and target membrane localized SNARE (t-SNARE) proteins can zipper-up and pull the membranes tightly together in α-helix bundle format [14] . When the merger of lipid bilayers takes place, through fusion, SNAREs are disassembled under energy consumption by the ATPase NSF, which becomes recruited to the SNARE complex through an adaptor called SNAP [15] .
Non-Trans-SNARE Configurations
If exocytosis is initiated by non-trans-SNARE configurations, there are at least three possible initial states for exocytosis. These are binary-SNARE, unitary-SNARE, and cis-SNARE [for details refer subtitle 1.2.2, 1.2.3, and 1.2.4]. It is not easy to identify which of these states is used for the initial configuration, and more than one configuration may be utilized for a particular type of exocytosis [16] - [18] .
Binary-SNARE Configurations
The binary t-SNARE complex of the two SNAREs (syntaxin and SNAP25) have been suggested that an intermediate stage of SNARE assembly. Auxiliary assembly of VAMP2 to form a trans-SNARE complex is the next stage of the fusion reaction. Binary-SNARE states are formed when the Munc18a/syntaxin1 complex binds to SNAP25 [16] , a process catalyzed by Munc13. A binary-SNARE complex can efficiently induce trans-SNARE complex formation upon increases in [Ca 2+ ] i because synaptotagmins bind with the binary-SNARE complex, as well as with membrane phospholipids, in a Ca 2+ -dependent manner. The binding of synaptotagmins with the plasma membrane supplies VAMPs within the vesicles to the binary complex in the plasma membrane. As a result VAMP2 can rapidly assemble with the binary complex [10] [19].
Unitary-SNARE Configurations
Unitary or free-SNAREs are a highly reactive form of SNARE complex and are an apparent candidate for the initial SNARE state. They named as unitary-SNAREs is to avoid the possible confusion that such SNAREs are completely free and not bound to other molecules, such as Munc18 [19] .
Unassembled SNAREs can be produced from ternary-and binary-SNARE complexes. Thus unitary-SNAREs are dynamically maintained and may be generated immediately before exocytosis is triggered. Unassembled syntaxin can be chaperoned by Munc18a, which bundle SNARE motifs and H abc for stabilization [10] [20] .
Regardless of the clamping role of Munc18a, Proteoliposome experiments showed that Munc18a facilitates the formation of the binary-SNARE and trans-SNARE complexes. Munc13 encourages dissociation of Munc18 from closed syntaxin and the formation of binary-and ternary-SNARE complexes [17] . If vesicles contact with the plasma membrane after stimulation, VAMPs and synaptotagmins introduce intimate contacts with syntaxins and SNAP25, and facilitate SNARE assembly [21] .
Cis-SNARE Complex Configurations and Its Disassembly
After exocytosis, cis-SNARE complex remains in the plasma membrane and this will be disassembled and recycled to another round of fusion events. Disassembly of the SNARE complex is facilitated by the NSF (Sec18p in yeast), and the contact between the SNARE complex and NSF requires SNAPs (Sec17p in yeast). NSF is a soluble ATPase, which contains an NH 2 -terminal domain and two ATP-binding domains. The extreme stability of the SNARE complex forced that the NSF to use energy derived from ATP hydrolysis to disassemble it. Three SNAPs (α, β and γ) are recruited from the cytoplasm to everyone SNARE complex in the membrane, and the resulting SNAP/SNARE complex recruits a NSF hexamer, leading to the disassembly of the SNARE complex [22] [23] . Mutations in NSF block synaptic transmission due to accumulation of syntaxin and SNARE complexes in synaptic vesicles. Microinjection of NSF peptides that inhibit the ATPase activity of NSF also inhibited synaptic transmission [24] [25] .
In contrast to SNAREs and atlastins, viral fusion proteins do not Trans-Oligomerizes in order to merge the two opposing membranes. Instead they bridge the two lipid bilayers via the formation of an extended intermediate that exposes a hydrophobic segment, termed fusion loop or fusion peptide, at the viral membrane distal end of the protein, such that it can insert into the target membrane. The extended intermediate then collapses into a hairpin that brings together fusion loop and viral transmembrane (TM) segments, thereby forcing the two membranes into close apposition [26] . SNAP-23 or NSF depletion and NSF-DN expression lead to defects in HIV-1 particle production. This defect correlates with a deficiency in Gag-membrane localization, suggesting a role for SNARE proteins in Gag accumulation at the Plasma Membrane [27] .
Exocytosis
Proteoliposome studies had showed that a single trans-SNARE complex is capable of inducing exocytosis, whereas other studies report that 3 or between 5 and 11 are required. Smaller numbers might reduce the fusion rate.
In living cells, at least two SNARE complexes are involved in synaptic transmission, and three to five SNARE complexes are involved in exocytosis in PC12 cells and Ca
2+
-primed chromaffin cells. Oligomers of SNAREs purified from the brain comprise three to five SNARE complexes [28] . On the other hand, cortical granule exocytosis (CGE) that is a calcium-regulated secretion during meiotic cell division of oocytes is thought to be mediated by the SNARE pathway [29] .
Synaptic Vesicles Exocytosis
The molecular mechanism of SNARE mediated membrane fusion has been intensively studied in synaptic vesicle fusion. Neurotransmitters released by presynaptic neurons are recognized by their receptors on postsynaptic neurons. Ca 2+ influx into the presynaptic cell then triggers membrane fusion between the presynaptic plasma membrane and synaptic vesicles, leading to the release of neurotransmitter [30] .
Fusion of synaptic vesicle with plasma membrane done by three neuronal SNARE proteins these are syntaxin, SNAP25 and synaptobrevin (also referred to as VAMP). One SNARE motif from synaptobrevin (v-SNARE) on a synaptic vesicle and three SNARE motifs provided by syntaxin-1 and SNAP25 (t-SNAREs) from the plasma membrane assemble into a tight trans-SNARE complex that brings the two membranes into close apposition. This close apposition, in turn, induces lipid bilayers merging, thus releasing neurotransmitter into the synaptic cleft [1] .
Other than the neuronal SNARE proteins, many other regulatory proteins, such as Munc18a and synaptotagmin, are required for synaptic vesicle fusion in vivo. Munc18a, a member of the Sec1/Munc18 (SM) protein family, appears to play a variety of roles in synaptic vesicle fusion. First, Munc18a binds to free syntaxin molecules and keeps them in a closed, inactive state, helping to prevent the formation of premature SNARE complexes. Additionally, Munc18a interacts with the syntaxin molecule within assembled t-SNARE complexes, guiding them in a manner conducive to productive trans-SNARE complex formation, which triggers membrane fusion. Neuronal synaptotagmin, anchored to synaptic vesicles, functions as a calcium sensor for synaptic vesicle fusion [31] [32] .
Synaptic vesicles in the presynaptic terminals of neurons undergo exocytosis in four different modes: ultrafast [33] , asynchronous [34] , tonic [35] , and spontaneous [36] . This suggests that the same types of vesicles show markedly different kinetics depending on the mode of exocytosis [34] .
Constitutive exocytosis of neurotransmitters occurs without any particular external stimulation and carries membrane lipids and membrane proteins to the plasma membrane, which is necessary for cell survival. TIRF imaging of constitutive exocytosis reveals that it occurs in a manner similar to regulated exocytosis. Constitutive exocytosis is mediated by SNAREs, as is the case for regulated exocytosis, and some secretory cells appear to utilize the same set of SNAREs as are utilized for constitutive exocytosis [37] [38].
Fusion Pore Formation and Its Role
The vesicle has an aqueous compartment inside and its first connection with the extracellular fluid is through an exocytotic fusion pore. Measurements of progress in exocytosis can be made in terms of growth of the fusion pore. Tight temporal control by intracellular calcium concentrations control fast exocytosis of synaptic vesicles and this process differs from other membrane fusion reactions. Assembly of the fusogenic SNARE-complex is formed by controlling SNARE-dependent fusion pathway. The core fusion machinery consists of SNAREs, synaptotagmin, Munc18, and complexin. Initial SNARE-complex assembly and control of docking of vesicles is done by Munc18. On the other side, complexin and synaptotagmin cooperate in positioning the SNARE-complex in a release-ready state. The energy situation for fusion is calcium triggered and is promoted by the effects of complexin and synaptotagmin. Fusion pore formation and expansion are the final steps and this allows release of the water-soluble vesicle content. In the exocytosis pathway, the fusion pore formation is the most complicated part because of its short time existence [33] .
Protein-protein and protein-lipid interactions lead to the fusion of vesicles with their target membranes. Vesicle fusion is guided by Rab 3 effectors, synaptotagmin III, nSecl, domains of the NSF chaperone and its adaptor SNAP. SNAREs are maintained in functional state by two chaperone systems HSC 70/αCSP/SGT and synuclein and any defects in these systems can lead to neuro-degeneration [39] . An auto-inhibitory closed confirmation of Syntaxin-1, binds to Munc18-1 and this protein is supposed to gate formation of SNARE complexes which has a role in membrane fusion. Many diverse presynaptic plasticity processes and diverse tethering factors depend on Ca 2+ and RIM proteins for inducing fusion [40] .
Two hypothesis/models are available currently to explain the formation of fusion pore which is an intermediate temporary structure. The first hypothesis claims that the fusion pore is composed of purely lipids of both membranes and SNARE-complex accelerates pore formation by bringing the membranes in close proximity [41] . The second model proposes a proteinaceous fusion pore and explains that transmembrane domains of SNARE proteins are incorporated into the pore [42] . It is also proved that at the transmembrane domain in the fusion pore, the vesicle SNARE (synaptobrevin-2) has a structural role with other two target plasma membrane SNAREs (Syntaxin and SNAP-25). These are able to draw the two membranes together in juxtaposition, and SNAREs remodel the lipid membranes. A contrasting hypothesis was proposed, which states that SNARE trans-membrane domains form a proteinaceous channel spanning both lipid bilayers [43] [44].
Trafficking of Glutamate Receptors in Neuronal Dendrites and Its Role in Regulating Inflammation
Activity dependent trafficking of glutamate receptors in postsynaptic dendrites is involved in the synaptic plasticity of glutamatergic synapses. Vesicles carrying glutamate receptors are found in the cytosol and undergo Ca 2+ dependent exocytosis. Thus docking and fusion of these vesicles must be induced in a Ca 2+ dependent manner to enable rapid activity dependent changes in synaptic functions. Since exocytosis is Ca 2+ dependent, these vesicles may fall into the same class as enlargesomes [22] .
Immune System and the Role of SNAREs in Immune Responses
Trafficking of molecules and membranes within cells is a prerequisite to all aspects of cellular immune function. Recycling of cell surface proteins and delivery are involved in processes such as secretion of immune mediators, ingestion of pathogens and activation of lymphocytes. All aspects of trafficking in innate and adaptive immune responses and its tight regulation is executed by SNAREs [45] .
The link between innate and adaptive immunity is provided by the dendritic cells. Antigens, recognized by dendritic cells through pattern-recognition receptors, toll-like receptors are able to initiate a specific immune response. The nature of antigen delimits dendritic cells to secrete distinct cytokines for pathogen clearance. The dysregulation of this process can lead to a number of inflammatory diseases. The secretion of cytokines from dendritic cells is a tightly regulated process and the role of SNAREs in dendritic cell functioning can be exploited as novel targets of therapy in inflammatory diseases [46] . The role of SNAREs in dendritic cells both as facilitators of secretion and as useful tools to determine the pathways of secretion in opposing binding partners on vesicles and target membrane gives us an opportunity to explore these proteins as novel targets in inflammatory diseases.
Cytotoxic T lymphocytes (CTLs) and Natural killer cells (NK) selectively kills virally infected or cancer cells. Lytic granules are released at the contact area with target cells at the immunological synapse (IS). Maturation of lytic granules at the IS by SNARE mediations and exocytosis. Familial Hemophagocytic Lymphohystiocytosis is a disorder in which the immune system produces too many activated immune cells (lymphocytes) called T cells and SNARE mediated fusion events are deregulated [Refer Table 2 ]. It is reported that Syntaxin 11 and Syntaxin binding protein-2 are mutated and this deregulates lytic granule release during CTL activation and CTL mediated cytotoxicity and FHL pathophysiology [47] .
The SNARE molecular machinery is involved in RBL-2H3 (Rat basophilic leukemia cell line) degranulation and probably depends on exocytosis process composed of Syntaxin 4, SNAP 23 and VAMP 8. V-SNARE which was originally localized in endosomal compartment functions in exocytosis and this possibility is due to the presence of VAMP8. It was also proposed that a secretory granule in mast cells is an intersection between exocytotic and endocytotic pathways and acts as a specialized compartment [48] . This process referred to as Endocytosis-Exocytosis coupling involves the incorporation of membrane during exocytosis. The endocytosis happens in mast cells after full collapse fusion, kiss-and run fusion, in which fusion pore just opens and closes without any significant membrane traffic. One can also observe multivesicular exocytosis, and bulk endocytosis that retrieves giant vesicles from the membrane [49] . The SNARE complexes are also reconstituted into individual SNARE proteins. This is made possible by the NSF ATPase and represents the energy consuming step of the SNARE cycle [50] - [52] . The kiss-and run exocytosis also known as "cavicapture" has been reported in chromoffin cells, and insulin-secreting pancreatic beta-cells and in mast cells. High calcium concentrations is known to shift the mechanism from kiss-and run to complete fusion. One SNARE complex is sufficient for the bilayer fusion and three SNARE complexes are required to prevent the nascent fusion pore from reclosing, and the stability of fusion pore can be altered by accessory proteins like complexin and Gβγ [53] .
Dendritic cell function can be better understood by identifying specific SNARE complexes and their regulators during inflammation. This could present potential therapeutic targets in a wide range of inflammatory diseases. The current strategy of using monoclonal antibodies and subsequent damages could be caused in cytokine production and blocking their activities. A number of antibody therapies in personalized medicine are being investigated. It was proposed that targeting SNARE proteins or other trafficking proteins and pathways which inhibit cytokine release could be an effective therapeutic approach in dendritic cells during inflammation [54] .
Role of SNARE Protein in Control of Tumor Formation and as an Important Target for Cancer Therapy
Published studies using human endothelial cells have shown that syntaxin 6 (Stx6), a member of the target membrane-associated SNARE (t-SNARE) family protein is associated with VEGFR2/KDR and alpha5 beta1 integrin trafficking and angiogenesis [55] . SNARE protein may have important roles in cancer cell signaling, progression, invasion and onset of cancer through different mechanism. Mammalian Qb SNAREs are involved in vesicular transport with interaction with t-SNAREs (Vti1b). Vt1b forms complexes with Syntaxin 7(Qa), and Syntaxin 8 (Q C ). Vti1b is involved in Golgi-derived vesicle budding and is localized in the intracellular membrane with t-SNARE proteins. In Cancer Biology, lysosomes and mediated fusion of endosomes with lysosomes are emphasized through VAMP-8 and autophagy. Autophagosomes are trafficked to lysosomes and degraded by lysosomal hydrolases and autophagy is known to promote malignant cell survival, inflammation and tumorigenesis [56] [57] .
In Glioblastoma which is most common and fatal type of primary brain tumor in adults, Stx1 over expression is detected, it is also expressed in small cell lung carcinoma and the most aggressive forms of colorectal cancer. the blockade of the SNARE protein Stx1 through three different approaches, including knock-down of Stx1a, expression of the H3TM dominant negative form of Stx1a and inhibition of Stx1 by treatment with BoNT/C1, consistently results in a dramatic decrease in glioblastoma tumor progression according to the study done in orthotopic mouse model. GBM in vivo experimental model study recommend that the possibility of using drugs [58] that targets Stx1 or other SNAREs [59] . Protein engineering of recombinant BoNT variants can he used to retarget BoNT SNARE-cleaving proteases into specific cell populations. Novel strategies have been devised in anticancer therapeutics to redirect BoNT protease into tumor cells by replacing neuronal binding domain with tumor targeting ligand. It is also possible to insert selected short peptide ligand into the loop region located between Light chain and Heavy chain in the BoNT molecule. This can trigger endocytosis in tumour cells rather than neurons and BoNT can translocate the SNARE protease into the cytoplasm. This will allow the cleavage of SNAREs and block the transportation of the signalling molecules which are known to cause tumorigenesis [60] [61].
In colorectal cancer, Netrin-1 receptor deleted in colorectal cancer forms a protein complex with Syntaxin-1 (Sytx1). This complex is Netrin-1 dependent both in vitro and in vivo, and requires specific Sytx1. Blockade of Sytx1 function by using various toxins, abolishes Netrin-1-dependent chemo-attraction of axons. Netrin-1 also provokes exocytosis at growing shafts in a Sytx1-dependent manner. Moreover, Sytx1/DCC complex associates with the v-SNARE in the spinal cord results in abnormal axonal direction phenotypes [62] . Silencing of SNARE protein NAPA sensitizes cancer cells to Cisplatin by inducing ERK 1/2 signaling, SINOVIOLIN ubiquitination and p53 accumulation. NAPA, an anti-apoptotic protein promotes degradation of tumor suppressor p53. The combination of Cisplatin and knockdown of NAPA represents a new strategy to eradicate p-53 sensitive cancer cells [63] . Table 1 provides the summary of some of the studies carried out to understand the SNARE functions together with associated proteins.
Hemophagocytic Lymphohystiocytosis (HLH) [ Table 2 ] with defects in cytotoxic activity and expansion of polyclonal CD-8 positive T cells and INF-gamma activated phagocytic macrophages, which infiltrates multiple organs and tissues including the nervous system cause neurological manifestations [86] .
SNARE-Associated Proteins and Its Functional Regulation Synaptotagmins and Other Ca 2+ Sensors in Neuronal Cell
Synaptotagmin 1 is enriched in synaptic vesicles and is the major Ca 2+ sensor particularly for ultrafast exocytosis. 3. Vamp-7 ATP transportation in cancer cell during autophagy stimulation immunogenicity of cancer cell death or inflammation.
[67]
4. Vamp-8 Required for secretion of all platelet granules, Platelets contain α-granules, dense (δ-) granules, and a few lysosomes.
[68]
5. Syntaxin-8
Glioblastoma multiform (GBM): it is driven by aberrant signaling of growth factor receptors (EGFR). Unique tumor suppression mechanism involve the regulation of receptor trafficking.
[69]
6. Syntaxin-3 & -4 Alpha 5 beta 1 and alpha 3 beta 1 integrin trafficking, cervical adenocarcinoma, PANC-1 pancreatic adenocarcinoma.
[70]- [72] 7. The presynaptic microinjection of synaptotagmin peptides or anti-synaptotagmin antibodies inhibits synaptic transmission. This protein contains two C2 domains (C2A and C2B), which are homologous to the regulatory C2 region of protein kinase C, both domains bind Ca 2+ via their loops [94] . Ca 2+ binding to the C2B domain is more vital for neurotransmitter release than Ca 2+ binding to the C2A domain. Disturbing Ca 2+ binding sites on the C2B domain has a significant effect on ultrafast exocytosis, whereas disturbance of Ca 2+ binding sites on the C2A domain has a small effect. Ca 2+ bounding to the C2B domain of synaptotagmin1 stimulate interaction between two opposite membranes due to its highly positive electrostatic potential against negatively charged phospholipid head groups [95] .
Asynchronous and spontaneous exocytosis lack synaptotagmin1, this indicates that asynchronous and spontaneous exocytosis are mediated by Ca 2+ sensors other than synaptotagmin1. Attractive candidates for a slow Ca 2+ sensor are the double C2domain (Doc2) proteins. Doc2 proteins are soluble proteins, which are enriched in synapses. Like synaptotagmins, these proteins contain C2 domains but have relatively high affinity for Ca
2+
. Elimination of Doc2 in cultured hippocampal neurons results in normal aroused responses, but decreases spontaneous release rate by 50% [96] .
Oncogene can control the potential expression of SNARE proteins as a consequence of numerous changes that are detected in human tumor cells through overexpression of Syntaxin 1, Syntaxin 2, Syntaxin 6, Syntaxin 7, and SNAP-25 [ Table 3 ].
Conclusion
Obviously, numerous studies were done on membrane fusion as fusion process is mediated and controlled by various proteins such as SNAREs, Rap GTPases and SM proteins. SNARE proteins can be classified into three classes-Synaptobrevin (VAMP2), Syntaxin and Synaptosome associated proteins (SNAP) and based on their amino acid contents they grouped into Q-SNARE that contain Glutamine and R-SNARE that contain Arginine. Dendritic cells secrete distinct cytokines by a tightly regulated process by highly conserved trafficking protein families. SNAREs are known to act as facilitators of secretion by inherent specificity and opposing binding partners on vesicles and target membranes. This role of SNAREs in dendritic cell functioning may give an opportunity to explore these proteins as novel targets of therapy in inflammatory diseases. Specificity of membrane fusion is largely dependent on SNARE proteins, because different SNAREpins can catalyze distinct fusion events. Both SM proteins and tethering factors play an active role in SNAREpin formation and as a result contribute to the specificity of the fusion as well as to its speed and high fidelity. The tethering factors influence Table 3 . Lists of changes and alterations in SNARE regulatory protein detected in human tumor potentially activated by oncogene (modified after Ref. [56] ).
Accessory protein
for SNARE Specific function of Accessary protein Ref.
Complexins/synaphins
It is expressed in the brain. It is important for ultrafast exocytosis and facilitates spontaneous exocytosis of NTs. In addition, It can inhibits liposome or cell-cell fusion by clamping full zippering of the trans-SNARE complex.
[28] [97] - [99] 
Munc13
It is necessary for ultrafast exocytosis of NTs. Munc13 removes the Munc18 capping from syntaxin, allow only one SNAP-25 molecule to bind syntaxin, whereby it prevents misfolding to the 2:1 complex.
[28] [100]- [102] Snapin It is identified as a SNAP25-binding protein and is expressed in both neuronal and non-neuronal cells. Snapin stabilizes the coupling between synaptotagmin1 and the SNARE complex during Ca 2+ -triggered ultrafast exocytosis at central nerve terminals.
[103] [104] Tomosyn It is identified as a syntaxin-binding protein in rat brain cytosol. Tomosyn is a negative regulator of exocytosis because it's over expression causes a significant reduction in exocytosis and its deletion causes enhanced neurotransmitter release through increased synaptic vesicle priming.
[105] [106] CAPS CAPS was originally isolated from brain cytosol as a factor required for Ca 2+ -triggered LDCV exocytosis. CAPS binds independently to each of the three SNARE proteins and markedly accelerates SNARE-dependent liposome fusion in vitro by promoting transSNARE complex assembly.
[107]
RIM It is a binding partner for Rab3, a highly abundant protein in synaptic vesicles. RIM facilitate SNARE assembly by reversing autoinhibitory homodimerization of Munc13.
[108]
CAST CAST directly or indirectly binds CAZ proteins to form a large molecular complex at the active zone. CAST also binds to RIM1 and, indirectly, to Munc13-1 to form a ternary complex. Deletion of CAST selectively affects the exocytosis of inhibitory synapses by reducing the size of the RRP.
[ 10] SNAREp in assembly through stabilization of SNARE proteins or the entire SNARE complex, gathering of t-SNAREs on the target membranes, or activating the assembly process by interacting with SM proteins. The direct physical interactions of tethering factors with SNAREs and SM proteins mediate docking and fusion of vesicles. As normal function of SNARE protein is valuable for cell survival, the over expression of SNARE proteins can promote cancer cell formation. As a result, targeting SNARE protein in various types of cancer cell may present an opportunity to explore novel methods of therapy in various inflammatory diseases. Novel functions of SNARE proteins and SNARE-related proteins such as Synaptotagmin, Synaptophysin, have been implied in tumorigenesis. Analysis of the mechanisms by which these proteins contribute towards cancer malignance, through selective proteolysis of SNAREs and understanding the causative agents for the induction of chemo-resistance, will be rewarding in the future. It is hoped that, novel anti-cancer therapeutics will be developed using targeted delivery of a SNARE-inactivating proteases which could modulate cellular signaling cascades in the cancer cells.
